The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer. (Q46140702)
Jump to navigation
Jump to search
scientific article published on 29 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer. |
scientific article published on 29 January 2009 |
Statements
The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer (English)
K-L Garm Spindler
N Pallisgaard
A A Rasmussen
J Lindebjerg
D Crüger